Abstract 5696: Genetic reprogramming of TAMs by engineered exosomes results in potent single agent anti-tumor activity

Sushrut Kamerkar; Dalia Burzyn; Olga Burenkova; Charan Leng; Raymond Yang; Katherin Kirwin; Tong Zi; Su Chul Jang; William Dahlberg; Eric Zhang; Scott Estes; Sylvie Maubant; Olivier Duchamp; Kyriakos Economides; Timothy Soos; Sriram Sathyanarayanan

doi:10.1158/1538-7445.AM2020-5696

Cancer Chemistry

Abstract 5696: Genetic reprogramming of TAMs by engineered exosomes results in potent single agent anti-tumor activity

Sushrut Kamerkar, Dalia Burzyn, Olga Burenkova, Charan Leng, Raymond Yang, Katherin Kirwin, Tong Zi, Su Chul Jang, William Dahlberg, Eric Zhang, Scott Estes, Sylvie Maubant, Olivier Duchamp, Kyriakos Economides, Timothy Soos and Sriram Sathyanarayanan

Sushrut Kamerkar

1Codiak BioSciences, Cambridge, MA;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Dalia Burzyn

1Codiak BioSciences, Cambridge, MA;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Olga Burenkova

1Codiak BioSciences, Cambridge, MA;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Charan Leng

1Codiak BioSciences, Cambridge, MA;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Raymond Yang

1Codiak BioSciences, Cambridge, MA;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Katherin Kirwin

1Codiak BioSciences, Cambridge, MA;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Tong Zi

1Codiak BioSciences, Cambridge, MA;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Su Chul Jang

1Codiak BioSciences, Cambridge, MA;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

William Dahlberg

1Codiak BioSciences, Cambridge, MA;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Eric Zhang

1Codiak BioSciences, Cambridge, MA;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Scott Estes

1Codiak BioSciences, Cambridge, MA;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Sylvie Maubant

2Oncodesign, Dijon, France.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Olivier Duchamp

2Oncodesign, Dijon, France.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Kyriakos Economides

1Codiak BioSciences, Cambridge, MA;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Timothy Soos

1Codiak BioSciences, Cambridge, MA;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Sriram Sathyanarayanan

1Codiak BioSciences, Cambridge, MA;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

DOI: 10.1158/1538-7445.AM2020-5696 Published August 2020

Article
Info & Metrics

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: August 2020 to April 2021

	Abstract	Full-text HTML	PDF
Total	330	0	0

Cited By

Article Information

Volume 80, Issue 16 Supplement, pp. 5696

DOI

https://doi.org/10.1158/1538-7445.AM2020-5696

Published By

American Association for Cancer Research

Print ISSN

0008-5472

Online ISSN

1538-7445

Author Information

Sushrut Kamerkar1,
Dalia Burzyn1,
Olga Burenkova1,
Charan Leng1,
Raymond Yang1,
Katherin Kirwin1,
Tong Zi1,
Su Chul Jang1,
William Dahlberg1,
Eric Zhang1,
Scott Estes1,
Sylvie Maubant2,
Olivier Duchamp2,
Kyriakos Economides1,
Timothy Soos1, and
Sriram Sathyanarayanan1

¹Codiak BioSciences, Cambridge, MA;
²Oncodesign, Dijon, France.

August 2020
Volume 80, Issue 16 Supplement

Table of Contents

Search for this keyword

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Abstract 5696: Genetic reprogramming of TAMs by engineered exosomes results in potent single agent anti-tumor activity

Message Subject (Your Name) has forwarded a page to you from Cancer Research

Message Body (Your Name) thought you would be interested in this article in Cancer Research.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Citation Tools

Abstract 5696: Genetic reprogramming of TAMs by engineered exosomes results in potent single agent anti-tumor activity

Cancer Res August 15 2020 (80) (16 Supplement) 5696; DOI: 10.1158/1538-7445.AM2020-5696

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Abstract 5696: Genetic reprogramming of TAMs by engineered exosomes results in potent single agent anti-tumor activity

Cancer Res August 15 2020 (80) (16 Supplement) 5696; DOI: 10.1158/1538-7445.AM2020-5696

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Jump to section

Article
Info & Metrics

Cited By...

Cancer Chemistry

Abstract 6550: WD105, a novel decursin derivative, showed greater growth inhibition and androgen receptor suppression in LNCaP human prostate cancer cells
Abstract 5683: Single-cell RNA-seq reveals heterogeneity, clonal evolution and strategies to overcome ibrutinib-venetoclax dual resistance in mantle cell lymphoma
Abstract 5676: Preclinical evaluation of estrogen receptor coregulator binding inhibitor ERX-245 in breast cancer

Show more Cancer Chemistry

Oral Presentations - Proffered Abstracts

Abstract PR01: Mitochondrial lactate metabolism in M2 macrophage polarization and ACL-dependent histone acetylation
Abstract PR05: Loss of PRC2 or KMT2D-COMPASS generates two quasi-mesenchymal cell states with distinct metastatic abilities
Abstract PR10: Alterations in carbon and nitrogen metabolism in lung cancer

Show more Oral Presentations - Proffered Abstracts

Oral Presentations - Novel Immunotherapies and Mechanisms

Abstract 5698: Novel conditionally active bispecific T cell engagers targeting solid tumors
Abstract 5695: Induction of lymphangiogenesis in breast cancer enhances responsiveness to immunotherapies

Show more Oral Presentations - Novel Immunotherapies and Mechanisms

Main menu

User menu

Search

Abstract 5696: Genetic reprogramming of TAMs by engineered exosomes results in potent single agent anti-tumor activity

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: August 2020 to April 2021

Cited By

Article Information

Author Information

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Cancer Chemistry

Oral Presentations - Proffered Abstracts

Oral Presentations - Novel Immunotherapies and Mechanisms

Articles

Info for

About Cancer Research